** Shares of MedAdvisor MDR.AX down 5% at A$0.19
** Stock hit lowest level since Dec. 27
** Medical software co says Q2 FY25 operating revenue fell by 38.6% to A$30.8 million ($19.20 million)
** However, co expects stronger second half through diversified U.S. pipeline for various health program, others
** Stock down 11.1% this year, as of last close
($1 = 1.6044 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。